Literature DB >> 28032940

The relationship between risk factors and medication adherence among breast cancer survivors: What explanatory role might depression play?

Louis C Markovitz1, Nicholas J Drysdale1, B Ann Bettencourt1.   

Abstract

OBJECTIVE: Despite the efficacy of clinical treatments (eg, adjuvant hormonal therapy) for breast cancer survivors (BCS), nonadherence rates remain high, increasing the risk of recurrence and mortality. The current study tested a theoretical model of medical nonadherence that proposes depression to be the most proximal predictor of medical nonadherence among BCS.
METHODS: Breast cancer survivors were recruited from radiation clinics in Missouri. Survey data were collected 12 months after the end of primary treatment. The sample size included 133 BCS.
RESULTS: Findings show substantial support for the model, demonstrating that depression mediated the relation between physical symptoms, cognitive symptoms, social support, and adherence to medication. This finding was replicated with a measure of mood disturbance.
CONCLUSIONS: These findings support the prediction that medication nonadherence among BCS multiply determined process and have compelling implications for healthcare providers and interventions designed to increase medication adherence among BCS.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer; depression; medication adherence; oncology; physical functioning

Mesh:

Year:  2017        PMID: 28032940     DOI: 10.1002/pon.4362

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  7 in total

1.  Physical Symptom Burden and Its Association With Distress, Anxiety, and Depression in Breast Cancer.

Authors:  Daniel C McFarland; Kelly M Shaffer; Amy Tiersten; Jimmie Holland
Journal:  Psychosomatics       Date:  2018-01-31       Impact factor: 2.386

2.  Allostatic Load as an Insight into the Psychological Burden after Primary Treatment in Women with Breast Cancer: Influence of Physical Side Effects and Pain Perception.

Authors:  Azzurra Irelli; Jessica Ranieri; Maria Maddalena Sirufo; Francesca De Pietro; Pamela Casalena; Lia Ginaldi; Katia Cannita; Dina Di Giacomo
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

3.  Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma.

Authors:  Jessica E Pritchard; Lauren E Wilson; Samuel M Miller; Melissa A Greiner; Harvey Jay Cohen; Deborah R Kaye; Tian Zhang; Michaela A Dinan
Journal:  J Am Geriatr Soc       Date:  2022-05-02       Impact factor: 7.538

Review 4.  The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review.

Authors:  Leanne Fleming; Sommer Agnew; Nicola Peddie; Megan Crawford; Diane Dixon; Iain MacPherson
Journal:  Breast       Date:  2022-05-14       Impact factor: 4.254

5.  Factors related to the resilience and mental health of adult cancer patients: a systematic review.

Authors:  Saori Tamura; Kumi Suzuki; Yuri Ito; Akiko Fukawa
Journal:  Support Care Cancer       Date:  2021-01-29       Impact factor: 3.359

6.  Characteristics and subtypes of depressive symptoms in Chinese female breast cancer patients of different ages: a cross-sectional study.

Authors:  Yanyan Li; Hong Liu; Yaoyao Sun; Jie Li; Yanhong Chen; Xuan Zhang; Juan Wang; Liuliu Wu; Di Shao; Fenglin Cao
Journal:  AIMS Public Health       Date:  2021-10-20

7.  Factors Related to Resilience, Anxiety/Depression, and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy in Japan.

Authors:  Saori Tamura
Journal:  Asia Pac J Oncol Nurs       Date:  2021-05-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.